Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials. (Q52600412)
Jump to navigation
Jump to search
scientific article published on 7 April 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials. |
scientific article published on 7 April 2018 |
Statements
1 reference
Assessment of the 1% of Patients with Consistent < 15% Reduction in Low-Density Lipoprotein Cholesterol: Pooled Analysis of 10 Phase 3 ODYSSEY Alirocumab Trials. (English)
1 reference
Harold E Bays
1 reference
Robert S Rosenson
1 reference
Marie T Baccara-Dinet
1 reference
Michael J Louie
1 reference
Desmond Thompson
1 reference
G Kees Hovingh
1 reference
1 April 2018
1 reference
32
1 reference
175-180
1 reference
2
1 reference
1 April 2018
1 reference
1 reference
Identifiers
1 reference
1 reference